Palmitic acid‐ and cysteine‐functionalized nanoparticles overcome mucus and epithelial barrier for oral delivery of drug
Bioengineering & Translational Medicine · 2023-05 · 8 (3)
DOI: 10.1002/btm2.10510 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioengineering & Translational Medicine, online erschienen am 23.03.2023. Verfasst von Yinzhuo Xie und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Nanobiomaterials and Immunology, Zhejiang Provincial Key Laboratory of Plant Evolutionary Ecology and Conservation, School of Life Scien…. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Nanoparticles (NPs) used for oral administration have greatly improved drug bioavailability and therapeutic efficacy. Nevertheless, NPs are limited by biological barriers, such as gastrointestinal degradation, mucus barrier, and epithelial barrier. To solve these problems, we developed the PA‐N‐2‐HACC‐Cys NPs loaded with anti‐inflammatory hydrophobic drug curcumin (CUR) (CUR@PA‐N‐2‐HACC‐Cys NPs) by self‐assembled amphiphilic polymer, composed of the N ‐2‐Hydroxypropyl trimethyl ammonium chloride chitosan (N‐2‐HACC), hydrophobic palmitic acid (PA), and cysteine (Cys). After oral administration, the CUR@PA‐N‐2‐HACC‐Cys NPs had good stability and sustained release under gastrointestinal conditions, followed by adhering to the intestine to achieve drug mucosal delivery. Additionally, the NPs could penetrate mucus and epithelial barriers to promote cellular uptake. The CUR@PA‐N‐2‐HACC‐Cys NPs could open tight junctions between cells for transepithelial transport while striking a balance between mucus interaction and diffusion through mucus. Notably, the CUR@PA‐N‐2‐HACC‐Cys NPs improved the oral bioavailability of CUR, which remarkably relieved colitis symptoms and promoted mucosal epithelial repair. Our findings proved that the CUR@PA‐N‐2‐HACC‐Cys NPs had excellent biocompatibility, could overcome mucus and epithelial barriers, and had significant application prospects for oral delivery of the hydrophobic drugs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Nanobiomaterials and Immunology, Zhejiang Provincial Key Laboratory of Plant Evolutionary Ecology and Conservation, School of Life Sciences, Taizhou University Taizhou 318000 China.
- Key Laboratory of Microbiology, College of Heilongjiang Province, School of Life Sciences, Heilongjiang University Harbin 150080 China.
- School of Pharmaceutical and Materials Engineering & Institute for Advanced Studies, Taizhou University Taizhou 318000 China.
- Tunku Abdul Rahman University of Management and Technology Jalan Genting Kelang Kuala Lumpur 53300 Malaysia.
ORCID-Profile: Kai Zhao
Zitieren
APA
Xie, Y., Jin, Z., Ma, D., Yin, T. H., & Zhao, K. (2023). Palmitic acid‐ and cysteine‐functionalized nanoparticles overcome mucus and epithelial barrier for oral delivery of drug. Bioengineering & Translational Medicine, 8(3). https://doi.org/10.1002/btm2.10510
Vancouver
Xie Y, Jin Z, Ma D, Yin TH, Zhao K. Palmitic acid‐ and cysteine‐functionalized nanoparticles overcome mucus and epithelial barrier for oral delivery of drug. Bioengineering & Translational Medicine. 2023;8(3). doi:10.1002/btm2.10510
BibTeX
@article{Xie2023,
author = {Xie, Yinzhuo and Jin, Zheng and Ma, Da and Yin, Tan Hui and Zhao, Kai},
title = {Palmitic acid‐ and cysteine‐functionalized nanoparticles overcome mucus and epithelial barrier for oral delivery of drug},
journal = {Bioengineering & Translational Medicine},
year = {2023},
volume = {8},
number = {3},
doi = {10.1002/btm2.10510}
}
EUVIMED